Skip to main content
Clinical Trials/CTRI/2009/091/000215
CTRI/2009/091/000215CompletedPhase 4

An open, prospective, multicentre study to assess the confidence, usability, preference and satisfaction on use of Revolizer in healthy volunteers and in subjects with mild asthma or COPD.

Cipla Ltd0 sites100 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Cipla Ltd
Enrollment
100

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Subjects and healthy volunteers willing to sign informed consent
  • 2. Subjects and healthy volunteers of 18 years and above
  • 3. Subjects with or without a respiratory condition. Each subject with a respiratory condition (prior experience of using an inhaler) should be matched as far as possible with an individual without a respiratory condition (inhaler naïve) with respect to the age, sex, literacy status etc
  • 4. Subjects with mild Asthma or COPD

Exclusion Criteria

  • 1. Subjects already using Dry Powder Inhaler (DPI) prior to start of the study.
  • 2. Subjects with co-ordination problems like Parkinson?s disease, mental illness, tremors etc.

Investigators

Sponsor
Cipla Ltd

Similar Trials

A clinical trial to assess the confidence,... | Clinical Trial